Asian cardiovascular & thoracic annals · 2007
Urokinase thrombolysis in acute-on-chronic vascular occlusion of lower limb.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shrivastava Chandra P, Devgarha Sanjeev
Аннотация
Between January 2000 and June 2003, 70 patients (63 men and 7 women) with acute-on-chronic lower limb vascular occlusion underwent thrombolysis with 1 million units of urokinase. Forty-eight patients had unilateral and 22 had bilateral involvement; 9 had gangrenous changes. The mean age was 47 +/- 9 years, 73% were smokers, and 13% had diabetes. The definition of a good response was either return of distal pulses or a warm limb and relief of pain at rest. Fifty-three (76%) patients (including 5 with gangrenous changes) had symptomatic improvement with thrombolysis (group 1), and 17 (24%) did not respond (group 2). All 70 patients (including 7 who later required amputation) underwent surgical intervention with a polytetrafluoroethylene interposition graft or arterioplasty. A good response to surgical treatment was found in significantly more patients (49/53, 92%) in group 1 compared to group 2 (7/17, 41%). Claudication distance after 6 months of follow-up improved in a significantly higher percentage of patients in group 1 (85%) than group 2 (38%). Preoperative thrombolysis improved the outcome and predicted the result of arterial surgery.
Предметные рубрики MeSH
Acute DiseaseAdultAmputation, SurgicalArterial Occlusive DiseasesBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationChronic DiseaseCombined Modality TherapyFemaleFibrinolytic AgentsFollow-Up StudiesHumansInfusions, IntravenousIntermittent ClaudicationLower ExtremityMaleMiddle AgedPain MeasurementPeripheral Vascular DiseasesPolytetrafluoroethyleneProsthesis DesignRetrospective StudiesThrombolytic TherapyTime FactorsTreatment OutcomeUrokinase-Type Plasminogen ActivatorVascular Surgical Procedures